General Information of the Compound
| Compound ID |
CP0419829
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-(3-bromobenzoylamino)-4-chlorobenzoic acid
Show/Hide
|
||||||||||||||||||
| Synonyms |
2-(3-Bromobenzamido)-4-chlorobenzoic acid
2-(3-bromobenzoylamino)-4-chlorobenzoic acid
2-[(3-bromobenzoyl)amino]-4-chlorobenzenecarboxylic acid
2-[(3-bromobenzoyl)amino]-4-chlorobenzoic acid
827325-60-0
AC1N8QX1
AKOS005107642
ALBB-022752
BDBM50158557
Benzoic acid, 2-[(3-bromobenzoyl)amino]-4-chloro-
CHEMBL225612
CTK3D6918
DTXSID50401927
KS-00003MRF
MCULE-7998531013
MS-0095
MolPort-002-885-931
R4909
SCHEMBL14075271
SR-01000309735
SR-01000309735-1
ZINC4104976
ZX-AN021268
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C14H9BrClNO3
|
||||||||||||||||||
| Molecular Weight |
354.587
|
||||||||||||||||||
| Canonical SMILES |
OC(=O)c1ccc(Cl)cc1NC(=O)c1cccc(Br)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C14H9BrClNO3/c15-9-3-1-2-8(6-9)13(18)17-12-7-10(16)4-5-11(12)14(19)20/h1-7H,(H,17,18)(H,19,20)
Show/Hide
|
||||||||||||||||||
| InChIKey |
NKUSVNRZDILGSG-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound